7-Chloro-N-(3,5-dimethoxyphenyl)quinazolin-4-amine

Catalog No. :
ACDQQY402
CAS No. :
477856-39-6
Molecular Formula :
C16H14ClN3O2
Molecular Weight :
315.76

IUPAC Name:7-chloro-N-(3,5-dimethoxyphenyl)quinazolin-4-amine

7-Chloro-N-(3,5-dimethoxyphenyl)quinazolin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-Chloro-N-(3,5-dimethoxyphenyl)quinazolin-4-amine
IUPAC Name7-chloro-N-(3,5-dimethoxyphenyl)quinazolin-4-amine
MDL No.MFCD01815346
Molecular FormulaC16H14ClN3O2
Molecular Weight315.76
SMILESCOC1=CC(OC)=CC(NC2=C3C=CC(Cl)=CC3=NC=N2)=C1
InChI KeyVRDFWBGQAAMFCT-UHFFFAOYSA-N
SynonymN-(7-CHLORO-4-QUINAZOLINYL)-N-(3,5-DIMETHOXYPHENYL)AMINE;7-CHLORO-N-(3,5-DIMETHOXYPHENYL)-4-QUINAZOLINAMINE;7-chloro-N-(3,5-dimethoxyphenyl)quinazolin-4-amine;4-Quinazolinamine, 7-chloro-N-(3,5-dimethoxyphenyl)-
CAS No.477856-39-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDQQY402 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUXHS982 route compound structure diagram
    ACUXHS98240891-33-6 In Stock
  2. Plus
  3. ACUPGV649 route compound structure diagram
    ACUPGV6492148-57-4 In Stock
  4. Then
  5. ACDQQY402 route product structure diagram
    ACDQQY402477856-39-6
Inquiry

2. ACDQQY402 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUXHS982 route compound structure diagram
    ACUXHS98240891-33-6 In Stock
  2. Plus
  3. ACTEZU302 route compound structure diagram
    ACTEZU30231374-18-2 In Stock
  4. Then
  5. ACDQQY402 route product structure diagram
    ACDQQY402477856-39-6
Inquiry

Comments (0)